November 10, 2021 — Philips, a global leader in health technology, announced that it has signed an agreement to acquire ...
November 10, 2021 — There were nine late-breaking trials and 13 late-breaking science presentations at the 2021 ...
November 9, 2021 — Results from the largest randomized trial available comparing different closure device strategies ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 9, 2021 — Utilizing a magnetically-controlled capsule endoscopy system, the double-blind, randomized OPT-PEACE ...
November 9, 2021 — Six-month outcomes from the randomized RADIANCE-HTN TRIO Trial comparing endovascular ultrasound ...
November 9, 2021 — The primary results of the Fractional Flow Reserve Versus Angiography for Multivessel Evaluation ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
November 9, 2021 — Results from SUGAR trial, a randomized, controlled, multicenter trial conducted exclusively in ...
November 9, 2021 — New five-year data from the SURTAVI trial found that there was no difference in all-cause mortality ...
November 9, 2021 — An economic analysis of data from PARTNER 3, a randomized trial comparing transcatheter aortic valve ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
November 9, 2021 — Use of a novel technique called the quantitative flow ratio (QFR) to precisely identify and measure ...
November 20, 2021 – Philips announced it signed an agreement to acquire Cardiologs, a France-based medical technology ...
November 9, 2021 — Caption Health and Ultromics, developers of artificial intelligence (AI) to improve cardiac ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
November 9, 2021 — The COVID-19 (SARS-CoV-2) virus does not infect blood vessels, despite the high risk of blood clots ...
November 9 2021 — A new large-scale, real-world analysis of Centers for Medicare and Medicaid Services (CMS) outcomes ...
November 8, 2021 – SWISS-APERO is the first randomized clinical trial comparing the Abbott Amulet left atrial appendage ...
November 10, 2021
